|
maps • volume xv number 2 • Summer 2005
|
Personal Account of MDMA Easing
Posttraumatic Stress Disorder (PTSD) Symptoms
By D., a 38-year old dentist, married with three children.
[ D . is referred to as "Gideon" in the article on page 10]
|
|
April 2004
In March 2002 I was in a cafe across the road from my
office in Jerusalem when a suicide bomber exploded next to
me. Amazingly I survived (although eleven others did not),
with permanent damage only to my hearing. I was later
diagnosed with PTSD. The presentation of PTSD can be
complex with many possible expressions, and my symptoms indicated the "arousal" type.
In my personal search to fulfill new psychological
needs, I began to use MDMA at parties. MDMA use in this
very social and very stimulatory context enabled me to
reach profound and satisfying levels of emotional experience.
At the same time I was getting psychological support
from a National Insurance-sponsored psychologist
(interestingly, she felt that my MDMA self-medication was a
way of attempting to gain control of the original traumatic
incident).
However, beyond these immediate effects, it was the
effect that lasted up to 48 hours following MDMA ingestion
that intrigued me. A cognitive exercise that I did
under the guidance of my psychologist, involving logging
all my PTSD occurrences, revealed consistently zero PTSD
manifestations for the two days following MDMA use. This
discovery is what prompted me to survey the literature
on MDMA in PTSD therapy, find MAPS, and prepare this
report at Dr. Doblin's request, in the hope it will help with
his effort to further study in this area. I must point out that
I have no experience with MDMA as part of psychotherapy,
nor do I have any reason to think it would be especially
beneficial in that context.
I am not happy using MDMA because, as production
and distribution of the material is both illegal and
unsupervised, I don't know exactly what composition I'm
ingesting, the effects vary according to the batch, and there
is also a negative social stigma.
I should also point out that I tried SSRIs on two separate occasions
(paroxetine and sertraline) but had to abort
because of side effects on my problematic gastrointestinal
system.
I would be happy to be able to use MDMA in a legal and
supervised context, and I therefore support Dr. Doblin in
his project.
An update in May 2005:
A year ago I wrote a report for MAPS on my personal
experience with MDMA. I reported that I was using
MDMA on a weekly basis in order to alleviate symptoms
of PTSD. Typically I would have an emotionally fulfilling
experience at the time of ingestion, followed by two days
free of PTSD symptoms. This would help me get through
the week while functioning normally and fulfilling my
obligations.
As an update, I can report a few interesting points from
my experience over the past year:
- Being treated all the while with conventional psychotherapy
sponsored by Israeli National Insurance,
I was prescribed antidepressants. As in the past, these
were eventually discontinued due to their numerous
and various side effects, from tremour and dry mouth
to gastrointestinal and sexual dysfunction. MDMA,
however, had no apparent side effects.
- I have not used MDMA for several weeks now in
order to test dependency. I can report that I have no
sense of desire for the substance and no withdrawal
symptoms, so apparently no dependence.
- Overall, I feel today more connected to life. I attribute
this to my two years of experience with MDMA
and the assistance it afforded me in reconnecting to
people, music, love, et cetera.
- MDMA, however, has not been a panacea, and I am
still struggling with PTSD.
I wish to emphasize the obvious, that my report is not
scientific by any means, and no operative conclusions
should be reached from it. And this is precisely why I support
MAPS. Proper long-term clinical research needs to be
done so we can ascertain the usefulness of MDMA.
Overall, I feel today more connected to life.
I attribute this to my two years of experience
with MDMA and the assistance it afforded me in
reconnecting to people, music, love, et cetera.
|
| Summer 2009 |
Vol. 19, No. 2 |
MAPS Research Update 2009 |
| Spring 2009 |
Vol. 19, No. 1 |
Special Edition: Psychedelics and Ecology |
| Winter 2008/09 |
Vol. 18, No. 3 |
MAPS 2008 Financial Report |
| Summer 2008 |
Vol. 18, No. 2 |
Phoenix Rising: A Review of MAPS Research |
| Spring 2008 |
Vol. 18, No. 1 |
Special Edition: Technology and Psychedelics |
| Winter 2007 |
Vol. 17, No. 3 |
MAPS 06-07 Fiscal Yearly Report |
| Autumn 2007 |
Vol. 17, No. 2 |
Special Edition: Psychedelics and Self-Discovery |
| Spring/Summer 2007 |
Vol. 17, No. 1 |
The Chrysalis Stage |
| Winter 2006-7 |
Vol. 16, No. 3 |
Low Maintenance/High Performance |
| Autumn 2006 |
Vol. 16, No. 2 |
Technologies of Healing |
| Spring 2006 |
Vol. 16, No. 1 |
MAPS' 20th Anniversary |
| Winter 2005 |
Vol. 15, No. 3 |
MAPS final year as a teenager |
| Summer 2005 |
Vol. 15, No. 2 |
Israel Conference: MDMA/PTSD Research |
| Spring 2005 |
Vol. 15, No. 1 |
Accelerating flow of work and time |
| Autumn 2004 |
Vol. 14, No. 2 |
Rites of Passage: Kids and Psychedelics |
| Summer 2004 |
Vol. 14, No. 1 |
10 stamps and $250,000 |
| Winter 2003 |
Vol. 13, No. 2 |
Holy Fire |
| Spring 2003 |
Vol. 13, No. 1 |
60th Anniversary of the Discovery
of LSD |
| Autumn 2002 |
Vol. 12, No. 3 |
Vision |
| Summer 2002 |
Vol. 12, No. 2 |
"From celebration to frustration,
and back again." |
| Spring 2002 |
Vol. 12, No. 1 |
Sex, Spirit & Psychedelics 2002 |
| Autumn 2001 |
Vol. 11, No. 2 |
"In the future, it will be called
Despair." |
| Spring 2001 |
Vol. 11, No. 1 |
"A Tidal Wave of Ecstasy!" |
| Autumn 2000 |
Vol. 10, No. 3 |
Creativity 2000 |
| Summer 2000 |
Vol. 10, No. 2 |
Endings and Beginnings |
| Spring 2000 |
Vol. 10, No. 1 |
Making History in Slow Motion |
| Winter 1999/00 |
Vol. 9, No. 4 |
To the Ends of the Earth for MDMA
Research... |
| Autumn 1999 |
Vol. 9, No. 3 |
MAPS' long-standing efforts to conduct... |
| Summer 1999 |
Vol. 9, No. 2 |
MAPS has come full circle... |
| Spring 1999 |
Vol. 9, No. 1 |
Patience, persistence and passion |
| Winter 1998/99 |
Vol. 8, No. 4 |
One of special pleasures of directing
MAPS... |
| Autumn 1998 |
Vol. 8, No. 3 |
The Ayahuasca Issue (with Hofmann
interview) |
| Summer 1998 |
Vol. 8, No. 2 |
Emotionally Powerful Anecdotes... |
| Spring 1998 |
Vol. 8, No. 1 |
Death Has a Way of Focusing One's
Attention |
| Autumn 1997 |
Vol. 7, No. 4 |
Celebration is in Order |
| Summer 1997 |
Vol. 7, No. 3 |
Time Horizons |
| Spring 1997 |
Vol. 7, No. 2 |
Synchronicity |
| Winter 1996/97 |
Vol. 7, No. 1 |
Learning to Crawl |
| Autumn 1996 |
Vol. 6, No. 4 |
An Invitation for Dialogue |
| Summer 1996 |
Vol. 6, No. 3 |
Budding Research |
| New Year 1996 |
Vol. 6, No. 2 |
Sending Down Roots |
| Autumn 1995 |
Vol. 6, No. 1 |
Baby Steps |
| Summer 1995 |
Vol. 5, No. 4 |
Opportunity Amidst Obstacles |
| Winter 1994/95 |
Vol. 5, No. 3 |
Clinical Trials and Tribulations |
| Autumn 1994 |
Vol. 5, No. 2 |
Building Towards Clinical Trials |
| Summer 1994 |
Vol. 5, No. 1 |
Politics and Protocols: In Search
of a Balance |
| Spring 1994 |
Vol. 4, No. 4 |
Laying the Groundwork |
| Winter 1993/94 |
Vol. 4, No. 3 |
A Time of Tests |
| Summer 1993 |
Vol. 4, No. 2 |
So Close Yet So Far |
| Spring 1993 |
Vol. 4, No. 1 |
Remembrance and Renewal |
| Winter 1992/93 |
Vol. 3, No. 4 |
Forging New Alliances |
| Summer 1992 |
Vol. 3, No. 3 |
Building on Common Ground |
| Spring 1992 |
Vol. 3, No. 2 |
Small Steps, Gradual Progress, New
Opportunities |
| Winter 1991/92 |
Vol. 3, No. 1 |
The Rekindling of a Thousand Points
of Light |
| Summer 1991 |
Vol. 2, No. 2 |
MDMA protocol development with cancer patients |
| Winter 1990/91 |
Vol. 2, No. 1 |
MAPS' Swiss pharmacologically-assisted psychotherapy
conference |
| Autumn 1990 |
Vol. 1, No. 3 |
What and Who is MAPS? |
| Summer 1989 |
Vol. 1, No. 2 |
Switzerland Leads the Way |
| Summer 1988 |
Vol. 1, No. 1 |
MDMA can become a legal medicine |
|
|
|